Quilt Health provides a digital platform connecting clinical care, community resources, and home support for individuals managing complex health conditions. This platform streamlines communication and coordination among patients, caregivers, and providers to improve access to high-quality treatment. The company focuses on reducing fragmentation in care delivery to help patients achieve longer, healthier lives.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with rare and complex diseases often face significant challenges in accessing appropriate clinical trials and treatments due to fragmented, inefficient, and inequitable access to cutting-edge care. This can result in delayed or missed opportunities for potentially life-saving therapies. A significant percentage of rare disease trials also fail to meet enrollment thresholds, further hindering the development and availability of new treatments.
Solution
Quilt Health is a digital health platform designed to accelerate access to transformative care for individuals with rare and complex diseases. By connecting provider, patient, and R&D communities, Quilt Health streamlines the process of matching patients to relevant clinical trials and treatments. The platform acts as an accelerator, powering research and development, expanding trial and treatment access, and removing barriers that can undermine years of progress and investment in innovative medicines. Quilt Health leverages data and technology to address the fragmentation and inefficiencies in the rare disease treatment landscape, ultimately aiming to improve patient outcomes and accelerate the delivery of transformative care.
Target Audience
The primary target audience includes patients with rare and complex diseases, their healthcare providers (physicians, specialists), and research and development organizations focused on developing new treatments for these conditions.
Features
- Engagement platform that connects patients, providers, and research communities.
- Streamlined access to clinical trials and innovative medicines.
- Data-driven matching of patients to relevant trials and treatments.
- Aims to power research and development in the rare disease space.
- Designed to expand trial and treatment access for patients with rare and complex diseases.
- Removes barriers to treatment, improving access to care.